Inflammatory Myofibroblastic Tumour

Watchlist

(log in to enable)

Retrieved

2021-01-18

Source

Wikipedia

Trials

—

Genes

ALK, RANBP2, TPM3, CLTC, TPM4, CARS1, ACVRL1, SLPI, ROS1, NTRK3, TP53, KIT, SMUG1, EML4, MDM2, TFG, COIL, IL1R1, STAT6, CD274, BCOR, WDR48, IL6, ACTB, DES, CDK4, ETV6, ATIC, FN1, HMGA2

ALK, RANBP2, TPM3, CLTC, TPM4, CARS1, ACVRL1, SLPI, ROS1, NTRK3, TP53, KIT, SMUG1, EML4, MDM2, TFG, COIL, IL1R1, STAT6, CD274, BCOR, WDR48, IL6, ACTB, DES, CDK4, ETV6, ATIC, FN1, HMGA2, STAM2, USP6, SQSTM1, TP63, CD34, SLBP, RBPMS, YWHAE, WT1, VIM, CDKN2A, CMD1B, TNFRSF8, ZC3H7B, SEC31A, TNF, BRAF, AMACR, CCND1, AZU1, HEBP1, ANO1, MIB1, ATF1, RTL1, WG, DUX4, MTCO2P12, TNS1, NKX2-1, HDLBP, TIMP3, HNRNPA1, IGF1R, IGFBP5, EWSR1, ESR1, LAG3, ERBB2, MKI67, COX2, NAB2, NHS, NPM1, NTRK1, PDGFRA, PIK3CA, PTGS2, DCTN1, RET, ACE, CCL2, SETMAR, CCN2, SMARCA1, SMARCA4, SMARCB1, SMN1, SMN2, CR2, TFE3, H3P10

Drugs

—

Interested in hearing about new therapies?

Inflammatory myofibroblastic tumour is a lesional pattern of inflammatory pseudotumour, as plasma cell granuloma. It is abbreviated IMT.

Symptoms

The symptoms depend on the specific location of the tumour, which can be anywhere in the body.

Pathology

Inflammatory myofibroblastic tumours are characterized by a mix of inflammatory cells, e.g. plasma cells, lymphocytes and eosinophils, and bland spindle cells without nuclear atypia. These tumours may have necrosis, hemorrhage, focal calcification and mitotic activity.

The histologic differential diagnosis includes:

calcifying fibrous pseudotumour
inflammatory fibroid tumour
nodular fasciitis.

Approximately half of IMTs have a rearrangement of the ALK gene.

Diagnosis

Inflammatory myofibroblastic tumours are diagnosed based on their appearance under the microscope, by pathologists. Medical imaging findings are non-specific.

Localization

Lung or Bronchus
Liver
Urinary bladder
Parotid

Treatment